不完全TACE后残留HCC在增强影像上的表现
本研究描述不完全TACE后残留HCC在CEUS和CE-MRI/CT上对比剂动力学的变化。29例经活检或血管造影证实的残留HCC患者,TACE后4-6周复查,CEUS上84.2%保留APHE而CE-MRI/CT仅57.1%;洗脱保留率CEUS为33.3%、CE-MRI/CT为18.8%。结论提示TACE可显著改变APHE和洗脱等典型诊断特征。
要点
- TACE后残留HCC的APHE和洗脱可能消失,不能因缺乏典型特征而排除残留。
- CEUS对TACE后APHE的显示率高于CE-MRI/CT,判读残留时需注意模态差异。
- TACE后洗脱征象保留率低,阅片时应结合治疗前影像对比。
核心结论
- TACE可显著改变初治HCC的典型增强特征如APHE和洗脱,诊断残留病灶时需考虑此影响。
研究设计与样本
- 回顾性研究纳入29例经活检、再治疗血管造影或4-8个月MRI证实肿瘤进展的残留HCC患者。
- 收集TACE前及TACE后4-6周CE-MRI/CT和CEUS检查,由两名有经验阅片者 blinded 独立评估APHE和洗脱,第三阅片者仲裁分歧。
关键影像表现/征象
- CEUS上基线有APHE者TACE后84.2%仍显示APHE(p=0.25);CE-MRI/CT上仅57.1%显示APHE(p=0.004)。
- CEUS上基线有洗脱者TACE后33.3%保留洗脱(p=0.01);CE-MRI/CT上仅18.8%保留洗脱(p<0.001)。
诊断标准与关键数值
- CEUS阅片者间基线APHE一致率100%,基线洗脱66.7%(K=0.35),TACE后APHE 84.2%(K=0.35),TACE后洗脱57.9%(K=-0.09)。
- CE-MRI/CT阅片者间基线APHE一致率65.5%(K=0.19),基线洗脱55.2%(K=0.12),TACE后APHE 48.3%(K=-0.07),TACE后洗脱58.6%(K=0.04)。
临床应用与阅片要点
- 阅片诊断TACE后残留HCC时,不应仅依赖APHE和洗脱,需对比治疗前影像并综合判断。
- CEUS与CE-MRI/CT对残留病灶增强特征的显示存在差异,必要时可互补使用。
- 注意TACE后洗脱征象保留率低,尤其CE-MRI/CT上更易消失,避免漏诊。
局限性
- 样本量较小(29例),可能影响统计效能和结果外推。
- 部分阅片者间一致率较低(如CE-MRI/CT TACE后APHE K=-0.07),判读存在主观差异。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
PURPOSE: The aim of this study was to describe changes in contrast agent kinetics in HCC following incomplete trans-arterial chemoembolization (TACE) on contrast-enhanced ultrasound (CEUS) and MRI/CT.
METHODS: Patients with residual HCC proven by biopsy, retreatment angiography, or 4-8 month MRI demonstrating tumor progression were identified. Pre-treatment and 4-6-week follow-up CE-MRI/CT and CEUS exams were collected for blinded reads by two experienced readers for each modality to evaluate arterial phase hyper-enhancement (APHE) and washout within the residual HCC. A third reader provided tie-breaking decisions for any disagreements.
RESULTS: Contrast-enhanced imaging data were collected from 29 patients with residual HCC post-TACE. On CEUS, 84.2% of patients with baseline APHE demonstrated APHE post-TACE (p = 0.25). On CE-MRI/CT, 57.1% of patients with baseline APHE later demonstrated APHE (p = 0.004). As for washout, on CEUS 33.3% of patients with baseline washout retained washout post-TACE (p = 0.01), while on CE-MRI/CT only 18.8% of patients with baseline washout later demonstrated washout (p < 0.001). Among CEUS readers, reader agreement was 100% for baseline APHE, 66.7% for baseline washout (K = 0.35), 84.2% for post-TACE APHE (K = 0.35), and 57.9% for post-TACE washout (K = - 0.09). On CE-MRI/CT, reader agreement was 65.5% for baseline APHE (K = 0.19), 55.2% for baseline washout (K = 0.12), 48.3% for post-TACE APHE (K = - 0.07), and 58.6% for post-TACE washout (K = 0.04).
CONCLUSION: Common diagnostic features of treatment-naïve HCC like APHE and washout can be substantially altered by TACE and should be considered when diagnosing residual disease on contrast-enhanced imaging.
引用
- Polikoff A, Wessner CE, Balasubramanya R, et al. Imaging appearance of residual HCC following incomplete trans-arterial chemoembolization on contrast-enhanced imaging. Abdom Radiol (NY). 2021. PMID: 34643782. doi:10.1007/s00261-021-03298-z
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。